Aflac Incorporated $AFL Shares Sold by HBK Sorce Advisory LLC

HBK Sorce Advisory LLC lowered its position in shares of Aflac Incorporated (NYSE:AFL) by 67.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,547 shares of the financial services provider’s stock after selling 15,997 shares during the period. HBK Sorce Advisory LLC’s holdings in Aflac were worth $796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in AFL. Mid American Wealth Advisory Group Inc. acquired a new stake in Aflac during the second quarter worth $26,000. Chilton Capital Management LLC purchased a new stake in Aflac in the 2nd quarter valued at about $26,000. Whipplewood Advisors LLC lifted its position in Aflac by 1,526.7% in the second quarter. Whipplewood Advisors LLC now owns 244 shares of the financial services provider’s stock valued at $26,000 after buying an additional 229 shares during the last quarter. AlphaCore Capital LLC acquired a new stake in shares of Aflac during the first quarter valued at about $28,000. Finally, Hilltop National Bank purchased a new stake in shares of Aflac in the 2nd quarter valued at approximately $32,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Insiders Place Their Bets

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $102.57, for a total transaction of $102,570.00. Following the completion of the sale, the director owned 25,105 shares in the company, valued at approximately $2,575,019.85. The trade was a 3.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.90% of the company’s stock.

Aflac Stock Performance

NYSE:AFL opened at $106.78 on Friday. Aflac Incorporated has a 12 month low of $96.95 and a 12 month high of $115.43. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.11 and a quick ratio of 0.11. The firm has a market capitalization of $57.11 billion, a PE ratio of 24.21, a price-to-earnings-growth ratio of 2.93 and a beta of 0.86. The business’s fifty day moving average price is $108.63 and its 200 day moving average price is $105.62.

Aflac (NYSE:AFL) last released its quarterly earnings data on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The business had revenue of $5.91 billion during the quarter. On average, sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac declared that its board has approved a share buyback plan on Tuesday, August 12th that authorizes the company to repurchase 100,000,000 outstanding shares. This repurchase authorization authorizes the financial services provider to purchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its stock is undervalued.

Aflac Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th were paid a $0.58 dividend. This represents a $2.32 annualized dividend and a yield of 2.2%. The ex-dividend date was Wednesday, August 20th. Aflac’s dividend payout ratio is currently 52.61%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Wall Street Zen raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. Morgan Stanley lifted their price objective on Aflac from $108.00 to $113.00 and gave the company an “equal weight” rating in a research note on Monday, August 18th. UBS Group reduced their price target on shares of Aflac from $114.00 to $111.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Evercore ISI set a $110.00 price objective on Aflac and gave the stock an “underperform” rating in a research report on Thursday, October 9th. Finally, Piper Sandler set a $125.00 target price on Aflac and gave the company an “overweight” rating in a report on Tuesday, October 7th. Three research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $109.45.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.